CDK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.753800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.261800E-01
Normal-vs-Stage2
8.065400E-01
Normal-vs-Stage3
7.137800E-02
Normal-vs-Stage4
1.659040E-01
Stage1-vs-Stage2
2.498200E-01
Stage1-vs-Stage3
4.288600E-01
Stage1-vs-Stage4
8.757000E-01
Stage2-vs-Stage3
8.433900E-02
Stage2-vs-Stage4
2.990100E-02
Stage3-vs-Stage4
1.551150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.524600E-01
Normal-vs-AfricanAmerican
7.323400E-01
Normal-vs-Asian
6.221400E-01
Caucasian-vs-AfricanAmerican
6.378400E-01
Caucasian-vs-Asian
5.039400E-01
AfricanAmerican-vs-Asian
9.760400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.705600E-01
Normal-vs-Female
9.813800E-01
Male-vs-Female
9.659800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.737000E-01
Normal-vs-Age(41-60Yrs)
3.704400E-02
Normal-vs-Age(61-80Yrs)
7.665600E-01
Normal-vs-Age(81-100Yrs)
6.719600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.039800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.692600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.521400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.675930E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.883700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.396400E-01
Normal-vs-Daily Drinker
7.791000E-01
Normal-vs-Weekly Drinker
9.891400E-01
Normal-vs-Occasional Drinker
4.819000E-01
Normal-vs-Social Drinker
8.626800E-01
Non Drinker-vs-Daily Drinker
9.017800E-01
Non Drinker-vs-Weekly Drinker
7.391200E-01
Non Drinker-vs-Occasional Drinker
3.069400E-01
Non Drinker-vs-Social Drinker
5.061200E-01
Daily Drinker-vs-Weekly Drinker
6.719400E-01
Daily Drinker-vs-Occasional Drinker
2.774800E-01
Daily Drinker-vs-Social Drinker
4.239400E-01
Weekly Drinker-vs-Occasional Drinker
6.072000E-01
Weekly Drinker-vs-Social Drinker
8.234600E-01
Occasional Drinker-vs-Social Drinker
6.989200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.540000E-01
Normal-vs-Grade 2
8.928400E-01
Normal-vs-Grade 3
9.489800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.233400E-04
Grade 1-vs-Grade 3
3.205800E-04
Grade 1-vs-Grade 4
7.540000E-01
Grade 2-vs-Grade 3
1.534810E-01
Grade 2-vs-Grade 4
8.928400E-01
Grade 3-vs-Grade 4
9.489800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.757800E-01
Normal-vs-NonDiabetic
9.585400E-01
Diabetic-vs-NonDiabetic
3.124400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.868800E-01
Normal-vs-NoPancreatitis
9.492400E-01
Pancreatitis-vs-NoPancreatitis
1.879550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.663800E-01
Normal-vs-N1
8.332600E-01
N0-vs-N1
8.637600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.228100E-02
Normal-vs-TP53-NonMutant
1.687160E-01
TP53-Mutant-vs-TP53-NonMutant
6.31770000000254E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
